1222PDRegional differences in overall survival (OS) in...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

1222PDRegional differences in overall survival (OS) in patients with advanced melanoma (MEL) who received nivolumab (NIVO) combined with ipilimumab (IPI) or NIVO alone in a phase 3 trial (CheckMate 067)

Grob, J-J., Schadendorf, D., Wagstaff, J., Márquez-Rodas, I., Lebbé, C., Ascierto, P.A., Hodi, F.S., Grossmann, K., Hassel, J.C., Walker, D., Bhore, R., Larkin, J., Wolchok, J.D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx377.009
Date:
September, 2017
File:
PDF, 98 KB
english, 2017
Conversion to is in progress
Conversion to is failed